Drug interactions between Avodart and Rapaflo
Interactions between your drugs
There were no interactions found in our database between Avodart and Rapaflo - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
- Avodart is in the drug class 5-alpha-reductase inhibitors.
- Avodart is used to treat Benign Prostatic Hyperplasia.
- Rapaflo is a member of the drug class antiadrenergic agents, peripherally acting.
- Rapaflo is used to treat Benign Prostatic Hyperplasia.
Drug and food interactions
Applies to: Rapaflo (silodosin)
Taking silodosin with food can reduce the risk and/or severity of side effects. Therefore, silodosin should be administered with or immediately after a meal.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No information available.|
Do not stop taking any medications without consulting your healthcare provider.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.